What’s new: CMS announces the newly proposed GLOBE (Global Benchmark for Efficient Drug Pricing) Model that would lower costs of drugs covered by Medicare Part B.
Why it matters: GLOBE would help make critical medications more accessible for people with Medicare, better enabling them to follow their prescribed care for optimal health outcomes, and alleviating financial strain on Medicare and for American taxpayers.
What to expect: CMS is seeking public comment on GLOBE through an NPRM, which is available on the Federal Register.
The big picture: This proposed drug model advances the Innovation Center’s commitment to help people with Medicare live healthier lives and promote the sustainability of the Medicare program through more affordable medications; it is part of the Trump Administration’s groundbreaking strategy to tackle rising drug costs for Americans.
Find out more:
